These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9271260)

  • 1. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.
    Harding JA; Engbers CM; Newman MS; Goldstein NI; Zalipsky S
    Biochim Biophys Acta; 1997 Jul; 1327(2):181-92. PubMed ID: 9271260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
    Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
    Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells.
    Mamot C; Ritschard R; Küng W; Park JW; Herrmann R; Rochlitz CF
    J Drug Target; 2006 May; 14(4):215-23. PubMed ID: 16777680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
    Mamot C; Drummond DC; Noble CO; Kallab V; Guo Z; Hong K; Kirpotin DB; Park JW
    Cancer Res; 2005 Dec; 65(24):11631-8. PubMed ID: 16357174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
    Kirpotin DB; Drummond DC; Shao Y; Shalaby MR; Hong K; Nielsen UB; Marks JD; Benz CC; Park JW
    Cancer Res; 2006 Jul; 66(13):6732-40. PubMed ID: 16818648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells.
    Deng L; Zhang Y; Ma L; Jing X; Ke X; Lian J; Zhao Q; Yan B; Zhang J; Yao J; Chen J
    Int J Nanomedicine; 2013; 8():3271-83. PubMed ID: 24023515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoliposome targeting to murine CD4+ leucocytes is dependent on immune status.
    Phillips NC; Gagne L; Tsoukas C; Dahman J
    J Immunol; 1994 Mar; 152(6):3168-74. PubMed ID: 7908302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo.
    Maruyama K; Takahashi N; Tagawa T; Nagaike K; Iwatsuru M
    FEBS Lett; 1997 Aug; 413(1):177-80. PubMed ID: 9287139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals].
    Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS
    Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
    Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
    Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG-immunoliposome.
    Maruyama K
    Biosci Rep; 2002 Apr; 22(2):251-66. PubMed ID: 12428903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity.
    Pan X; Lee RJ
    Int J Pharm; 2007 May; 336(2):276-83. PubMed ID: 17212981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
    Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
    Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
    Maruyama K; Kennel SJ; Huang L
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of immunoliposomes: reactivity against species-specific IgG and liposomal phospholipids.
    Phillips NC; Dahman J
    Immunol Lett; 1995 Mar; 45(3):149-52. PubMed ID: 7558165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.